Tokyo Tape
Sign in

Sawai Group Holdings

4887.TTSE PRIMEPharmaceutical
Key numbers · FY ended 2026-03
Revenue¥201.7bn+6.7% YoYOperating income¥15.9bn+292.4% YoYNet income (owners)¥10.4bn-12.8% YoYTotal assets¥359.9bn+1.5% YoYEPS (basic)¥90.39-6.4% YoY

Full financial history and reports →

Stock price4887 · View chart ↗

Open the price chart on TradingView.

Latest filings
Fri, Nov 6 · JST1 filing
14:465% STAKESawai Group Holdings · Silchester International Investors LLP · 6.85% → 7.91%+1.06pp
Mon, Sep 28 · JST1 filing
11:135% STAKESawai Group Holdings · Silchester International Investors LLP · 5.82% → 6.85%+1.03pp
Tue, May 27 · JST1 filing
09:50MATERIALSawai Group Holdings · Event with a material impact on financial position
Fri, Jul 19 · JST1 filing
11:51MATERIALSawai Group Holdings · Event with a material impact on financial position

All filings →

Major holders (5%+) · 3
HolderStakeChangeFiled
Silchester International Investors LLP7.91%+1.06pp2026-11-06
Nomura Asset Management Co., Ltd.6.46%-1.14pp2026-07-22
SOMPO ASSET MANAGEMENT CO., LTD.5.40%—2026-05-22

Each holder's own ratio from its most recent large-shareholding report.